Trends in Lyme disease incidence in England, 2013 to 2024
Deze studie analyseert gegevens uit 2013–2024 om aan te tonen dat hoewel het aantal in het laboratorium bevestigde gevallen van de ziekte van Lyme in Engeland stabiel bleef, de diagnoses in de eerstelijnszorg significant toenamen, wat een update van de vermenigvuldigingsfactor voor het schatten van het totale aantal jaarlijkse gevallen van 2,35 naar 6,20 noodzakelijk maakt.
Oorspronkelijk artikel gelicentieerd onder CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Dit is een AI-gegenereerde uitleg van een preprint die niet peer-reviewed is. Dit is geen medisch advies. Neem geen gezondheidsbeslissingen op basis van deze inhoud. Lees de volledige disclaimer
Lyme disease is a bacterial infection passed to humans through the bite of an infected tick. In England, the most common early sign is a spreading skin rash at the bite site, which doctors can often recognise with the naked eye. Because this rash is so distinctive, many people are diagnosed and treated by their general practitioner (GP) without ever needing a blood test. However, official government statistics on how many people get sick rely almost entirely on the number of cases that do have a blood sample sent to a national reference laboratory for confirmation. This creates a gap in the data: the official numbers miss unknown proportion of the people diagnosed with Lyme disease, simply because they were treated without the need for a blood test. Public health officials have used a rough estimate in the past to calculate an estimate for the true total, assuming that for every lab-confirmed case, there were roughly two and a half total cases. However, this estimate is based on old data, and the way GPs diagnose and treat the illness has changed since then.
A team of researchers from the UK Health Security Agency set out to update this picture using data from 2013 to 2024. They gathered two sets of information: the list of confirmed Lyme disease cases from the national laboratory and a subset of anonymised GP medical records across England. By comparing these two streams of data year by year, they could see how many more people were being treated by their GP compared to how many were being confirmed in the lab. The researchers found that the number of lab-confirmed cases has remained relatively steady over the last decade, with only minor fluctuations. In contrast, the number of people diagnosed and treated in primary care has risen significantly, growing by an average of nearly 500 additional cases each year.
This divergence means the old method of estimating the total number of people newly-diagnosed with Lyme disease each year is no longer accurate. The researchers calculated a new "multiplication factor," which is a number used to scale up the lab results to estimate the full picture. The old factor, derived from data ending in 2016, suggested that for every one lab case, there were roughly two and a half total cases. The new analysis shows that the ratio has shifted. For the most recent years, from 2020 to 2024, the researchers found that for every lab-confirmed case, there are now about six cases diagnosed by GPs. This change pushes the estimated total number of acute Lyme disease cases in England for 2024 from roughly 2,200 to nearly 6,000.
The study also looked at why this shift might be happening. One possibility is that new national guidelines introduced in 2018 encouraged doctors to treat patients based on the rash alone, without waiting for lab confirmation. While the data did not show a sudden jump in numbers when those guidelines were released, the steady rise in primary care diagnoses since then suggests that awareness and adherence to these guidelines have grown over time. One of the limitations pointed out by the authors was that the updated numbers could be overstimates, as they counted every consultation where a doctor wrote down a Lyme disease relevant diagnosis and prescribed antibiotics. This might have meant that some cases where the diagnosis was uncertain or the rash was mistaken for something else were included when they shouldn’t have been. Despite this, the study concludes that the true burden of the disease is likely higher than previously thought.
By updating the multiplication factor to reflect the current situation, the researchers provide a clearer view of the public health landscape. Instead of an estimated total of 3.8 Lyme disease cases per 100,000 people, the new data suggests the rate is closer to 10.1 cases per 100,000. It is important to note that this rate remains far lower than in neighbouring European countries. The authors emphasise that this new number should be used for future planning, but they also warn that the ratio between lab cases and community cases is not fixed. As medical practices and disease patterns continue to evolve, these estimates will need to be recalculated regularly to ensure that health officials have an accurate understanding of how many people are truly affected by Lyme disease in England.
Verdrinkt u in papers in uw vakgebied?
Ontvang dagelijkse digests van de nieuwste papers die bij uw onderzoekswoorden passen — met technische samenvattingen, in uw taal.